NeoLight is proud of the dedicated team of engineers, product developers, managers, sales and strategic relationship managers who are bringing our ideas to the marketplace.


Arik Anderson


Arik has extensive experience in leading growth stage companies including Somanetics where he led expansion into PICU and NICU markets resulting in a successful exit to Covidien for $350M, turnaround of $500M Terumo Cardiovascular and US market entry of digital health startup, Adherium Ltd.

Vivek Kopparthi

Co-founder & Executive Chairman

Vivek is a Cofounder of NeoLight and serves as its CEO. Prior to launching NeoLight, he has held leadership roles in organizations with 100+ employees, advised tech start-ups, and has consulted with major corporations. Vivek holds a bachelor’s degree in electrical engineering and a masters in management.

Siva Palaniswamy

Co-founder & CTO

Siva is a co-founder and serves as a Chief Technology Officer of Neolight. Siva developed the original idea for Skylife and is currently leading the research, design, and development of new neonatal medical devices for Neolight. He has been in the medical industry for almost 7 years now and has developed numerous medical devices for Asian, European & US markets in the neonatal field. He has a passion for integrating novel solutions from different fields to solve a problem in a chosen field to improve quality of life.

Deepak Shyam Krishnaraju

Co-founder & Lead R&D Engineer

Deepak has 5+ years’ experience in medical device design and engineering during which he has designed 3 medical devices – 1 FDA cleared. He is a published author of several engineering publications and patents. At NeoLight, Deepak plays a crucial role in validating new products in R&D and translating them for production. He supports executive leadership with market analysis, product placement strategy, intellectual property strategy, clinical trial management, and technical marketing.

Mark W. Schwartz, Ph.D.


Mark is the Vice President, Business Development for NeoLight. Among other executive positions, he has served as CEO of Galena Biopharma (NASDAQ), Apthera, Bayhill Therapeutics and Caylx Therapeutics. Mark’s extensive experience across operational and strategic management in early stage companies led him to his new role at NeoLight. He is an adjunct faculty member at San Jose State University and currently serves as a Director of Targazyme, Inc.

Julie Meyer


As NeoLight’s Chief Financial Officer, Julie manages the Finance, Accounting and Human Resource functions.  Julie has over 25 years of experience as a finance professional with significant mergers & acquisitions advisory and CFO experience.  Julie holds a BS with a concentration in Accounting from the University of Virginia and an MBA from the Tuck School at Dartmouth College.

Judith Hall, RNC, NIC-E


As NeoLight’s Clinical Director, Judy leads all efforts to ensure that NeoLight’s products pass all clinical trials. In this capacity she executes strategic partnerships with hospitals and research centers. Judy’s health care experience includes serving as the founder of Clinical Solutions and the Manager of Clinical Development for Verinata Health.